Company intelligence / Profile preview

Pascal Biosciences

Vancouver, British Columbia, Canadapascalbiosciences.com ↗
Ownership
Private
Development stage
Other
01

Overview

Pascal's lead programs included:

  • PAS‑403 — a small molecule therapeutic advancing toward clinical trials for glioblastoma with demonstrated activity in animal models and blood-brain barrier penetration.
  • PAS‑393 — an immuno-stimulatory cannabinoid designed to enhance the efficacy of checkpoint inhibitor therapies; preclinical data showed immune cell recruitment to tumors.
  • A B-cell targeted antibody program aimed at acute lymphoblastic leukemia.
Therapeutic areas
OncologyInfectious Diseases
Modalities
Small moleculesCannabinoid-based therapeuticsMonoclonal antibodies
Industry
Biotech
02

Drug pipeline

2 assets

PAS-393

Preclinical

1 more asset in the full pipeline.

03

Partnerships

SōRSE Technology Corporation – collaboration on oral cannabinoid delivery formulation optimized for clinical use with checkpoint inhibitors.Mitacs – partnership supporting cancer research at University of British Columbia.

Beyond the preview

Go deeper on Pascal Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pascal Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call